臺灣健保癌症用藥事前審查實作指引
1.0.1 - release
臺灣健保癌症用藥事前審查實作指引
1.0.1 - release
This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v1.0.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
藥物使用狀態：completed
藥物處方終止原因：Try another treatment first (MedicationRequest Status Reason Codes#altchoice)
意圖：Order ( medicationRequest Intent#order)
自費註記：健保 (NHI-藥物類型#nhi)
藥品代碼：ANTI-CUGH SYRUP 60ML (臺灣健保用藥品項#A000755151)
病人：Patient/pat-min ""
藥品使用頻率及服用時間：1W3D
藥物每次處方劑量(單位)：4 (tablets (Common UCUM units#{tbl}))
藥物處方起始日期：2024-05-01
藥物處方終止日期：2024-05-07
給藥途徑／作用部位：Oral use (SNOMED CT + 臺灣健保署給藥途徑值集#26643006)